Also. . .
Reuters
* Mentor Corp., one of the biggest manufacturers of saline-filled breast implants, denied a published report that a Food and Drug Administration investigation is linked to irregularities in breast implant studies. Shares in Santa Barbara-based Mentor plunged as much as 50% at the open before trading was halted, but the shares rebounded sharply after the company issued its statement on the USA Today report. Mentor shares closed down $3.56 at $30.50 on Nasdaq.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
